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Severe hyperkalemia following ileostomy not colostomy 
in a patient undergoing chronic hemodialysis
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ABSTRACT  In patients with end-stage renal disease (ESRD), the intestinal tract may assume 
an accessory potassium (K+) excretory role in the face of declining renal excretory function. 
Here, we report the case of a patient with ESRD who developed severe hyperkalemia following 
ileostomy not colostomy. A 6△-year-old woman undergoing hemodialysis began developing 
severe hyperkalemia after ileostomy. Previously, she had successfully undergone resection and 
colostomy of the transverse colon. The pre-dialysis serum K+ level was normal. Our present 
case demonstrates the importance of intestinal K+ secretion, especially in the colon, for 
maintaining hemostasis in patients with ESRD.
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〈Case Report〉
INTRODUCTION
   Potassium (K+) is the second most abundant cation 
in the body. Only 2% of the total-body K+ is located 
in the extracellular fluid compartment. The serum 
K+concentration is determined by the relationship 
between the K+ intake and the distribution of K+ 
between cells, and the extracellular fluid and 
urinary K+ excretion. The body has a marked ability 
to protect against disturbances in K+ metabolism. 
However, disorders of K+ metabolism are common 
in patients with chronic kidney disease, especially 
in those undergoing long-term hemodialysis 
(HD)１）. Furthermore, in long-term HD patients, 
hyperkalemia has been associated with a higher 
mortality２，３）. Under normal conditions, healthy 
individuals absorb most of the K+ they ingest from 
their diet, and they excrete an equal amount in the 
urine. When severe renal dysfunction supervenes, 
severe hyperkalemia is expected. However, severe 
hyperkalemia does not develop. Earlier studies４） 
have demonstrated that intestinal excretion of K+ 
increases in severe renal dysfunction, and it may 
play an important role in reducing K+ retention. 
   Here, we report on a case of severe hyperkalemia 
following ileostomy not colostomy in a patient 
undergoing chronic HD, and discuss the possible 
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pathophysiological mechanisms to account for this 
clinical finding.
CASE REPORT
   A 6△-year-old woman began HD in 199X 
for  ends tage  rena l  fa i lu re  due  to  chron ic 
glomerulonephritis. In February 200X, the patient 
was admitted to the Department of Digestive 
Surgery at our hospital because of a perforated 
transverse colon. She successfully underwent 
resection and colostomy of the transverse colon, 
resumed outpatient dialysis treatment afterwards. 
In October 200X, the patient was readmitted for 
ileal perforation due to intestinal obstruction, and 
she underwent resection of the ascending colon, 
followed by ileostomy. A stoma was constructed 
approximately 70 cm from the terminal ileum, 
and the rectal side stump was closed. Despite an 
uneventful postoperative course, the patient began 
to develop severe hyperkalemia postoperatively. 
Although she had regular HD, the pre-dialysis 
serum K+ elevated soon after each HD. She had no 
remarkable symptoms or signs of hyperkalemia.
   She was admitted to our hospital to assess for 
the severe hyperkalemia. Results of the physical 
examination were as follows: height, 163 cm; 
weight, 36.5 kg; blood pressure, 120/60 mmHg; 
heart rate, 68 beats/min; and respiratory rate, 
16 breaths/min. Her skin was dry, and palpebral 
conjunctiva showed signs of mild anemia. No 
cardiopulmonary abnormalities were observed. 
Two stomas were noted on the abdominal wall. 
Although the ileostomy caused loose stools, only 
a small amount of intestinal fluid, but no passage, 
appeared from the stoma of the transverse colon. 
The patient had undergone uncomplicated HD 
for 4 hours three times a week, and dialysis 
parameters included blood flow of 200 mL/min 
and Kt/V of 1.96 using a VPS-13HA dialyzer 
(Asahi Kasei Medical Co, Osaka City, Japan). 
Despite being anuric, the patient’s interdialytic 
weight gain was 1-2 kg. Hemodynamics during 
dialysis were stable; however, laboratory findings 
were remarkable for severe hyperkalemia (Tables 
1, 2). Despite high serum potassium levels, there 
were no signs of muscle weakness. In addition, 
we did not observe characteristic peaked T waves, 
widened QRS with absent P waves, or sine-wave 
patterns on electrocardiogram. To exclude the 
possibility that HD was not sufficiently removing 
K+, that serum K+ levels were examined before and 
after HD. We confirmed serum K+ significantly 
decreased after each HD session. Additionally, the 
results of blood gas analysis showed no evidence 
of severe metabolic acidosis as a potential cause 
of hyperkalemia. We again instructed the patient 
Table 1. Laboratory data on admission 
K, potassium.
Hematology
WBC 5,930 /mL
RBC 261 × 104 /mL
Hb 9.8 g/dL
Ht 29.9 %
Plt 13.2 × 104 /mL
Biochemistry
TP  　6.0 g/dL
Glu  　124 mg/dL
AlP  　232 IU/L
T-Cho  　99 mg/dL
LDH  　168 g/dL
Alb 　3.1 g/dL
ChE 　161 IU/L
ALT 　4 IU/L
AST 　11 IU/L
Table 2. Changes in the metabolic status before and after 
hemodialysis
Pre-dialysis Post-dialysis Unit
Crn 7.86 2.04 mg/dL
BUN 67 15 mg/dL
UA 7.7 1.5 mg/dL
Na 136 138 mEq/L
K 6.6 3.5 mEq/L
Cl 107 102 mEq/L
P 3.5 1.4 mg/dL
Ca 8.4 9.1 mg/dL
pH 7.355 7.444
HCO3- 18.8 27.4 mEq/L
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to avoid ingesting high K+ foods such as starfruit, 
bananas, oranges, raisins, and various vegetables. 
Even with the aforementioned management, 
hyperkalemia was still noted before the next HD 
session. Despite the restriction of K+ and the 
administration of calcium polystyrene sulfonate (30 
g/day), pre-dialysis K+ levels continued to be around 
6 mEq/L. These findings strongly suggested that 
severe hyperkalemia in our patient was caused by 
ileostomy not colostomy, and therefore colonic K+ 
secretion was significantly reduced (Fig. 1).
DISCUSSION
   In this report, we present a case of severe 
hyperkalemia in a patient with ESRD and anuria 
who underwent chronic HD. Our patient had a 
well-controlled stable pre-dialysis K+ level prior 
to ileostomy. We assumed that ileostomy was the 
etiology of hyperkalemia.
   Data obtained from patients with varying degrees 
of renal failure have suggested that increased 
fecal K+ begins to contribute to maintaining the 
K+ balance when the glomerular filtration rate 
decreases below 5 mLl/min. This is the same point 
at which residual nephrons develop their maximal 
capacity to secrete K+ into the urine４）. Intestinal 
excretion is caused by an increased net K+ secretion 
in the colon, and not a reduction in K+ absorption５）. 
A previous study reported that the colon removed 
up to 30-40 % of K+ ４）. Hayes et al.６，７） reported 
metabolic balance studies on patients with HD 
and found that fecal K+ excretion was abnormally 
high. Several patients excreted >50 mE/day in their 
stool. Dialysis patients are also known to sweat 
higher amounts of K+ than normal, suggesting that 
various mechanisms are recruited to compensate for 
a reduction in urinary K+ excretion. However, the 
mechanism of enhanced fecal K+ excretion is not 
completely understood.
   We calculated the K+ balance in the present case. 
The daily K+ intake in healthy individuals is 80-
100 mEq. Dialysis patients should restrict their 
K+ intake to 40-60 mEq per day, and 40-120 mEq/
L (1.5 mEq/kg) of K+ are usually removed within 
3-5 hours of HD, with an additional 0.3 mEq/kg/
day of K+ excreted in the feces. Sodium polystyrene 
sulfonate is sometimes used in the clinical field. 
An HD patient with anuria and the same weight 
as our case removes 54.75 mEq of K+ per dialysis 
session (1.5 mEq/kg × 36.5 kg) or 164.25 mEq 
Fig. 1. The clinical course. The patient began to develop severe hyperkalemia after ileostomy. WBC, 
white blood cell; RBC, red blood cell; Hb, hemoglobin; Ht, hematocrit; Plt, platelet; TP, total protein; 
Glu, glucose; AlP, alkaline phosphatase; T-Cho, total cholesterol; LDH, lactate dehydrogenase; Alb, 
albumin; ChE, cholinesterase; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
(mEq/L)
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Excretion in urine
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Intestinal excretion
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Excretion by dialysis
(54.75 mEq/dialysis)
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Intake Excretion
240 mEq/week280 mEq/week
Fig.2, Yorimitsu
Fig. 2. K+ balance in the dialysis patient (body weight, 36.5 kg). Crn, creatinine; BUN, blood urea 
nitrogen; UA, urine analysis; Na, sodium; K, potassium; Cl, chlorine; P, potassium; Ca, calcium; 
HCO3-, bicarbonate.
per week. In addition, the intestinal tract excretes 
10.95 mEq/day of K+ (0.3 mEq/kg × 36.5 kg) or 
76.65 mEq/week of K+ in the feces. Therefore, our 
case excreted approximately 240 mEq of K+ weekly, 
which is similar to the amount of K+ intake per 
week (Fig. 2). However, the present patient could 
not excrete K+ via the intestinal tract, and she was 
overloaded with 10.95 mEq/day of K+. Based on the 
assumption that the amount of the extracellular fluid 
was 7.3 L, the serum K+ level would increase by 
approximately 1.5 mEq/L per day (i.e., 3.0 mEq/L 
between dialysis sessions provided every other day). 
This value matches recent laboratory findings and 
strongly suggests that the continuously severe K+ in 
the present case was caused by impaired excretion 
of K+ through the intestinal tract, especially the 
colon. A previous case report８） showed sever 
hyperkalemia following colon diversion surgery in a 
maintenance hemodialysis patient. As for the cause 
of the hyperkalemia, the involvement of reduced 
colon K+ secretion was suspected due to temporary 
ileostomy. After the bowel continuity was restored, 
hyperkalemia improved. This case also is consistent 
with our deliberations.
CONCLUSIONS
   Our case demonstrates the importance of intestinal 
K+ secretion, especially in the colon, for maintaining 
of hemostasis in patients with ESRD. The clinical 
course of the present patient helped elucidate the 
importance of K+ excretion via the gastrointestinal 
tract, especially in the colon, in patients with 
impaired renal function.
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